Duviphar SRL
Duviphar reported total assets of €1.76m at the end of the 2025 financial year (annual accounts filed with the NBB on 25 Aug 2026).
The score of Duviphar shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Total assets +28 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Duviphar's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 25 Aug 2026
- Year ended 31 Dec 2024filed on 31 Jul 2025
- Year ended 31 Dec 2023filed on 30 Aug 2024
- Year ended 31 Dec 2022filed on 22 Dec 2023
- Year ended 31 Dec 2021filed on 31 Aug 2022
Duviphar's financial analysis
- Solvency0.9%sector median: 40.1%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Duviphar
Duviphar's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0829.596.062
- VAT number
- BE0829596062
- Peppol
- Registered · 0208:0829596062 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 23 Sep 2010
- Registered office
- 7340 Colfontaine
- Latest accounts
- 2025 · filed on 25 Aug 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Duviphar (SRL) has been based in Colfontaine since 2010, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 49,077 € and equity of 15,663 €; its revenue is not published. Its solvency stands at 0.9%, below the median of its sector (40.1%).
Companies similar to Duviphar
Companies in the same business, of comparable size and area, outside its group.
- Pharmacie DE Neef - Duez Retail sale of pharmaceutical products Mons · balance sheet 181,026 €
- Apotheek Gevaert Retail sale of pharmaceutical products Waregem · balance sheet €1.77m
- Vantieghem - Van Burm Retail sale of pharmaceutical products Avelgem · balance sheet €1.75m
- Apoteek Jespers - Cuijpers Retail sale of pharmaceutical products Anderlecht · balance sheet €1.72m
- MDV Pharma Retail sale of pharmaceutical products Genappe · balance sheet €1.71m
- SikaCare Retail sale of pharmaceutical products Hasselt · balance sheet €1.82m
- Gofran Retail sale of pharmaceutical products Zonhoven · balance sheet €1.71m
- Delputte Marie SRL Retail sale of pharmaceutical products Awans · balance sheet €1.85m
Frequently asked questions about Duviphar
What is the revenue of Duviphar?
Duviphar files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Duviphar?
In Belgium, the VAT number is the company number prefixed with BE: BE0829596062 for Duviphar, if the company is VAT-registered. Its company number (CBE) is 0829.596.062.
Where is the registered office of Duviphar?
According to the CBE register, the registered office of Duviphar is in 7340 Colfontaine.
What is the equity of Duviphar?
At the close of the 2025 financial year, the equity of Duviphar amounts to 15,663 €, a solvency of 0.9% of total assets.
Who manages Duviphar?
The register lists 1 active mandates at Duviphar. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Duviphar
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →